Can a smartphone app help manage serious mental illness?

NCT ID NCT05725785

Completed Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a smartphone app called FOCUS, along with coaching from trained clinicians, could help people with serious mental illnesses like schizophrenia and bipolar disorder. 191 participants used the app and received coaching over 12 weeks. Researchers measured changes in symptoms, recovery, and quality of life to see if this digital approach works as well as earlier studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FOCUS smartphone application and mobile health coaching
What this could lead to: If successful, this approach could provide a practical way to deliver mental health support through smartphones, making care more accessible.
What could go wrong: This is a completed implementation study, not a large-scale efficacy trial. Results may not apply to all settings or populations, and app-based support may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder major depressive disorder Psychotic Disorders schizoaffective disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DISORDER MAJOR DEPRESSIVE DISORDER SCHIZO AFFECTIVE DISORDER SCHIZOPHRENIA

Contacts and locations

Locations

Community Partners

Dover, New Hampshire, 03820, United States
Places for People

St Louis, Missouri, 63118, United States
The Mental Health Center of Greater Manchester

Manchester, New Hampshire, 03103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.